Radiotherapy enhances responses of lung cancer to CTLA-4 blockade
Abstract Formenti et al. have recently reported the clinical outcomes and translational readouts of a trial of the anti-CTLA-4 inhibitor, ipilimumab, in combination with palliative radiotherapy in 39 patients with non-small cell lung cancer. A radiological response was seen in 18% of patients and 31...
Salvato in:
| Autori principali: | , , , |
|---|---|
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
BMJ Publishing Group
2019-03-01
|
| Serie: | Journal for ImmunoTherapy of Cancer |
| Soggetti: | |
| Accesso online: | http://link.springer.com/article/10.1186/s40425-019-0542-z |
| Tags: |
Nessun Tag, puoi essere il primo ad aggiungerne!!
|